|
|
Books > Medicine > Clinical & internal medicine > Endocrinology > General
Scientific interest in regulatory T cells has revived during the
last decade. Initially described in the early seventies as
suppressor T cells, the concept of suppressor/regulatory T cells
went through turbulent times during the eighties when molecular
analysis failed to identify putative suppressor genes. The
constructive and elegant cellular experiments on regulatory T cells
during the nineties, initiated by Shimon Sakaguchi and co-workers,
however have brought these cells back into the limelight. Nowadays,
regulatory T cells are regarded as essential components of the
immune system, and several different subsets of regulatory T cells
have been described. Considerable regulatory function has been
attributed to the CD4+CD25+ T cell subset. These cells act by
suppressing adaptive and possibly also innate immune responses
thereby maintaining or restoring the balance between immunity and
tolerance. The suppressive effects of CD4+CD25+ regulatory T cells
are cell-contact dependent but a role for soluble factors,
particularly in vivo, has been suggested as well.
The aim of this book is to bring together recent developments and
viewpoints in the field of CD4+CD25+ regulatory T cells and to
discuss the potential use of regulatory T cells in immunotherapy of
inflammatory diseases. By linking data on regulatory T cells from
experimental models with recent findings from the clinic, this
topical book will be of interest to immunologists and other
biomedical researchers as well as clinicians that are interested in
regulation and manipulation of the immune response during (chronic)
inflammatory disease.
This book is the latest volume in the World Clinics Diabetology
series, focusing on complications associated with diabetes. Divided
into 13 sections, the first chapters discuss complications in
different organs and body systems, including the musculoskeletal
system, liver, skin, lungs, ear, nose and throat, and more. The
following sections cover stroke and diabetes, screening for
diabetic retinopathy, errors in insulin treatment, routine
investigations for complications, and diabetic kidney injury. The
comprehensive text is enhanced by more than 160 images and
illustrations, and each article is followed by a comment from the
editors highlighting the key points of the topic. Key points Latest
volume in World Clinics Diabetology series Covers complications
associated with diabetes in various organs and body systems Each
article concludes with a comment from the editors highlighting key
points Highly illustrated with clinical photographs and figures
The book aims to review knowledge on the disorders of eating
behaviour and body composition in some of the non-primate higher
animals and to relate these to similar conditions in humans. With
advances in understanding the nature of these disorders and their
biological basis, it seems timely to assess what cross-species
comparisons can tell us about the general underlying factors at
work. This may also help to delineate what may be a general
biological basis that humans share with their higher animal comrade
species and what may distinguish human from non-human, particularly
in a cultural context. This could help in combating better the
problems of these conditions in the animal species as well as in
man and in suggesting well-based preventive measures. As far as
people are concerned the last two decades of the 20th century have
shown a significant increase in obesity in the richer countries,
particularly the USA (Table 1). Possibly associated with the
obesity boom, there is an increasing awareness of other disorders
of eating behaviour and body composition. These range from anorexia
nervosa, at the other end of body composition to obesity, to
others, such as bulimia, with more variable effects on body
composition.
In mammals, a robust physiologic system acts to maintain relative constancy of weight. A key element of this system is leptin. The nature of this "brain-somatic" cross talk is as yet poorly understood, but it is likely to have important implications for the pathophysiology and treatment of obesity, diabetes and other metabolic disorders.
The study of the effects of gonadal hormones in the brain focussed
mainly on reproductive actions for a long time. Meanwhile, however,
it is well known that gonadal hormones, in particular estrogens,
also have neuroprotective and psychoprotective properties. They
modulate many brain functions such as cognitive functions, pain
regulation, motor coordination, and epilepsy, as well as affective
and psychotic disorders, to name just a few. In fact, during the
past few years we have experienced a major change in our
understanding of the endocrinologic aspects of psychiatric
disorders. Endocrinologic irregularities in psychiatric patients
are no longer viewed as pure epiphenomena but rather discussed as
part of the pathomechanism of the disorders. How exactly estrogens
affect various disorders is a fascinating and intriguing aspect of
this emerging field of non-reproductive brain actions of gonadal
hormones. Among the estrogens, especially estradiol appears to play
an important and multimodal role in the brain. Which of estradiol s
many membrane, intracellular, and genomic actions matters most in
psychiatric disorders, remains to be discovered. The aim of this
volume is to summarize the role estrogens play in major psychiatric
disorders, such as schizophrenia, depression, and dementia, and to
provide a state-of-the-art overview of current knowledge, but also
of questions that are still open. It is intended to be a resource
for clinicians and readers who are interested in contemporary
research developments in this field.
Myelodysplastic syndromes are to the bone marrow what pneumonia is
to the lungs; the response of an organ to a variety of etiologic
insults like aging, toxic exposure, infections and auto-immunity.
Among infectious causes alone, pneumonia could be the result of a
variety of possible pathogens including bacterial, viral,
tuberculous or fungal agents. Similarly, MDS cannot be treated as a
single disease. Attempts to harness the inherent complexity of MDS
by devising classifications' which group the various syndromes as
one disease is as misguided as saying that a pneumonia is not
infectious because it did not respond to antibiotics. Progress in
the field will occur faster when we re-analyze this premise.
Therefore, until a clearer picture of the disease emerges it is
best to treat each of the MDS syndromes as a separate entity.
Having no classification is better than a misleading one. Cancer
research has been notable for its periodic cycles of promise and
hope, followed by defeat and disappointments. It is not that there
is no solution, but that the problem has not been identified
precisely. This book is our attempt to define the most crucial
questions related to MDS that need to be addressed immediately
through logic, analysis and rigorous experimentation. If the
emerging problems appear daunting, then instead of being
overwhelmed by them, we should follow the advice of the great 20th
century thinker Antonio Gramsci, pessimism of the intellect must be
faced with the optimism of will'.
Since the first description of Philadelphia chromosome-negative
chronic myeloproliferative disorders more than 100 years ago, the
diagnosis and therapy of these conditions have been based primarily
on clinical experience and judgement. Until recently very little
was known about the molecular basis of these diseases. In order to
spark research in this area basic scientists and clinicians from
various parts of the world have contributed to this volume, the
first of its kind to put together the current knowledge. The book
deals with the new WHO classification of these disorders, novel
aspects of diagnostic pathology, the search for disease-relevant
genes utilizing molecular biology and proteomic techniques, the
description of the roles of PVR-1 and VHL genes for polycythemias
and the discovery of the gene mutation responsible for the
idiopathic hypereosinophilic syndrome. A chapter on anagrelide, an
important novel drug for the treatment of primary thrombocythemia,
is included.
Although phosphorylation of proteins on tyrosine is relatively rare
compared to phosphorylation on serine or threonine residues, the
past two decades of research into PTP function have led to a great
appreciation of the critical role PTPs have in regulating basic
cellular processes. Among these important roles is the regulation
of cellular signaling pathways related to metabolism. This volume
contains chapters which highlight many aspects of PTP function in
the context of metabolism. Given the growing obesity and diabetes
epidemics in the United States and throughout the world, the desire
to identify possible therapeutic targets for treatment of these
diseases is a high priority. In many ways, PTPs may be attractive
drug targets since they are amenable to targeting with small
molecules; however many challenges abound in making PTP inhibitors.
Amenorrhea: A Case-Based Clinical Guide is a comprehensive review
of the current knowledge regarding normal female reproductive
physiology. Replete with interesting case vignettes and providing
diagnostic algorithms and therapeutic strategies for amenorrhea,
Amenorrhea: A Case-Based Clinical Guide is divided into three
sections. The first section is composed of two chapters that
provide a thorough review of basic science and clinical knowledge
about the organ systems responsible for normal physiology of the
menstrual cycle. The second section includes discussion about
menstrual cycle disruption as it relates to hypothalamic-pituitary
dysfunction, surgical and natural menopause, genetic defects,
premature ovarian failure/insufficiency and the effects of caloric
excess and restriction. The third section offers an update on the
physiological effects of prolonged amenorrhea induced surgically or
by hypothalamic dysfunction and also includes an original chapter
that focuses solely on the impact of race and ethnicity on the
prevalence and diagnosis of amenorrhea. Amenorrhea: A Case-Based
Clinical Guide brings together chapters from renowned experts who
offer state-of-the-art, clinically useful information in a
case-based, reader-friendly fashion. This title will be a welcome
addition to the bookshelves of all clinicians who practice in
women's health settings.
As per the directives from Ministry of Health and Family Welfare,
Government of India, the National Board of Examinations (NBE) would
be conducting a computer-based multiple choice questions (MCQs)
examination. Candidates appearing for DM (Endocrinology) Entrance
Examinations would be expected to answer 40% questions from the
feeder specialty and 60% questions would be in Endocrinology. This
book is aimed to give students an idea of the kind of questions
that they might expect/anticipate in the examinations. Based on the
pattern of NEET DM Endocrinology entrance examination. Presented in
an easy to read layout. Divided into 25 chapters as per the
pattern. Concise answers and explanations. References from standard
textbooks. Useful diagrams and tables are incorporated.
Provides a view of the complicated interaction of glucose
metabolism with various endocrine hormones. This book covers
various endocrinopathies which may cause secondary diabetes or are
associated with metabolic syndrome and complications/comorbidities
of diabetes that may delay the diagnosis of endocrine dysfunction.
It also looks at different endocrinotropic drugs that may be used
to manage diabetes or may be involved in worsening of diabetes.
Written by experts in the field with wide clinical and research
experience. Presented in an easy to read format. A valuable
resource for endocrinologists, diabetologists, clinicians and
postgraduate students.
This book reports the text of the lectures of the 6th International
Conference on Sodium Calcium Exchange held in Lacco Ameno in the
Island of Ischia in the Gulf of Naples, Italy, from October 1 to
October 5, 2011. The present book uncovers the most striking new
findings on NCX that emerged since the previous Conference on
Sodium Calcium Exchange, such as the structural dissection of the
molecular determinants of Ca2+ sensitivity of the exchanger, the
epigenetic regulation of ncx1 gene, the molecular identification of
the mitochondrial Sodium Calcium Exchanger, and the discovery of
NCX in unexpected anatomical locations such as the female
reproductive tract. The book is organized into 11 parts covering
NCX structural aspects, genetic and epigenetic regulation,
regulatory mechanisms, subcellular localization in mitochondria,
involvement in neurodegenerative diseases and in immune regulation,
and the role of the cardiovascular and endocrine systems, as well
as diabetes in physiology and pathophysiology. Selected chapters of
the book are also devoted to the interaction of NCKX and other ion
channels and transporters with NCX, like ASICs, TRPM, and NHE.
This book is an essential handbook on bisphosphonates, the most
widely used new class of drugs for osteoporosis therapy. It reviews
basic physiology in addition to the indications and adverse
reactions of these drugs. Bisphosphonates in Bone Disease, 4E,
discusses the compounds' chemistry, mechanisms of action, and
animal toxicology before presenting a clinical picture of the
diseases treated by bisphosphonates. The book provides a table
listing the trade names of the commercially available
bisphosphonates, registered indications, and the available forms
for various countries. The revised Fourth Edition contains
approximately 50% new material, including information on all of the
latest drugs.
* The revised fourth edition contains approximately 50% new
material
* Includes information on all the latest drugs
This book is intended as a quick-reference book for
endocrinologists, endocrine trainees and physicians dealing with
common endocrine problems. It will be useful both in the wards and
the busy out-patient clinics. The information contained in this
booklet should be supplemented with clinical judgment and in-depth
reading from a bigger textbook. Simple and user-friendly. Divided
into eight chapters: Clinical Biochemistry: Reference Ranges;
Evaluation of Endocrine Disorders; Endocrine Test Protocols;
Treatment Protocols; Endocrine Emergencies; Diabetes Protocols;
Common Calculations and Scoring Systems; and Drug Doses. New
tabular format is added for testing protocols. Reference ranges
mentioned in this booklet are taken from the Department of Clinical
Biochemistry, Christian Medical College, Vellore, Tamil Nadu,
India. Treatment protocols are for adult patients.
This is a pocket guide for all professionals in countries where
access to care for diabetic feet is needed. Diabetic foot problems
and amputation represent the most important long-term problems of
diabetes medically, socially, and economically, and interest in the
diabetic foot is therefore steadily increasing. The management of
the diabetic foot disease requires expertise of a wide range of
specialists care on modern diabetic foot care and this
well-illustrated book provides a comprehensive, update review of
medical and surgical aspects of diabetic foot disease. The
practical approach will make this new edition an essential and
useful reading tool for all professionals aimed at managing the
diabetic foot, It focuses on the key aspects of diagnosis,
management, education, and prevention of diabetic foot diseases of
patients with diabetes.
The book is in question and answer format, very easy and
comfortable to read. It incorporates objective structures practical
examination (OSPE) and other format on Endocrinology questions.
Contents of the book have been updated as per the latest guidelines
by various endocrine organizations all over the world, especially
American Association of Clinical Endocrinology (AACE) guidelines,
American Diabetes Association (ADA), European Association for the
Study of Diabetes (EASD), American Thyroid Association (ATA)
guidelines, and other organizations of the world.
|
You may like...
I Make
Tracy Blom, Jimmy DiResta
Hardcover
R519
Discovery Miles 5 190
Pendulum
S E German
Hardcover
R663
Discovery Miles 6 630
|